(Total Views: 350)
Posted On: 11/12/2020 8:42:50 PM
Post# of 72
I inquired about adding a sign up feature for SEC filings and PR's:
Christopher Reinhard (CReinhard@Angionetics.com)
To:you Details
Hi xxxxx Many thanks for your email. Its an excellent suggestion. We have a signup to follow the company at the bottom page of the clinical trial tab (pls view), but I think that signup would be better in the investors and press tabs. Regards, Chris Reinhard
Gene Biotherapeutics | Cardiac Angiogenic Gene Therapy Finding New Ways To Heal
Gene Biotherapeutics is a publicly-traded, clinical development-stage biotechnology company engaged in the clinical advancement and commercialization of DNA-based biotherapeutics, primarily for the treatment of cardiovascular disease.
https://genebiotherapeutics.com/
Sent from Mail for Windows 10
Christopher Reinhard (CReinhard@Angionetics.com)
To:you Details
Hi xxxxx Many thanks for your email. Its an excellent suggestion. We have a signup to follow the company at the bottom page of the clinical trial tab (pls view), but I think that signup would be better in the investors and press tabs. Regards, Chris Reinhard
Gene Biotherapeutics | Cardiac Angiogenic Gene Therapy Finding New Ways To Heal
Gene Biotherapeutics is a publicly-traded, clinical development-stage biotechnology company engaged in the clinical advancement and commercialization of DNA-based biotherapeutics, primarily for the treatment of cardiovascular disease.
https://genebiotherapeutics.com/
Sent from Mail for Windows 10
(0)
(0)
